Answers are grounded in this paper and cite their sources.
A large cohort analysis shows better outcomes in pediatric patients with SCD and AIS, indicating treatment effectiveness.
BACKGROUND: There are significant risk factors and consequences of acute ischemic stroke (AIS) in pediatric sickle cell disease (SCD) patients, and currently no studies have analyzed the associations between SCD and pediatric AIS in a large, highly powered cohort. METHODS: Querying the National Inpatient Sample (NIS) database from 2016 to 2019, we identified patients with a primary diagnosis of AIS using the International Classification of Diseases, 10th Edition (ICD-10) codes. We compared pediatric patients without SCD (AIS-non-SCD) to those with SCD (AIS-SCD) across various parameters, including demographic characteristics, comorbidities, acute stroke indices, inpatient complications, and treatments. Primary outcomes analyzed included length of stay (LOS), discharge disposition, and inpatient mortality. CONCLUSIONS: Pediatric AIS-SCD patients demonstrated lower complication rates and superior outcomes, despite discharge placement to acute rehabilitation and long-term care facilities. Enhanced awareness and timely presentation could potentially increase AIS diagnosis rates in the pediatric population with sickle cell disease.
No takes yet. Share an insight, caveat, or question.
Graifman et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: